Aclaris Therapeutics, Inc. (ACRS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ACRS
See up to 3 months of ACRS. The 7-day demo opens the 1M and 3M ranges and puts ACRS on your watchlist.
Start 7-day demoLatest ACRS insider trades
About Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. files with the SEC under CIK 0001557746 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ACRS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 72,750 | |
| Tax withholding / forfeiture | 1 | 12,385 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ACRS insider transactions (Form 4)
8334 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Roland Wilhelm Kolbeck - Officer | Option exercise | Common Stock | 36,375 | - footnote F1 | - | |
| Roland Wilhelm Kolbeck - Officer | Tax withholding / forfeiture | Common Stock | 12,385 | $5.20 | $64K | |
| Roland Wilhelm Kolbeck - Officer | Option exercise | Restricted Stock Units | 36,375 | $0.00 | - | |
| ||||||
| Andrew N. Schiff | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| Andrew N. Schiff | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Andrew N. Schiff | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| ||||||
| Anand Mehra | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| Anand Mehra | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Anand Mehra | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Anand Mehra | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| ||||||
| Christopher P. Molineaux | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| Christopher P. Molineaux | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Christopher P. Molineaux | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Christopher P. Molineaux | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| ||||||
| William D. Humphries | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| William D. Humphries | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| William D. Humphries | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| William D. Humphries | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| ||||||
| Vincent Milano | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| Vincent Milano | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Vincent Milano | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Vincent Milano | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| ||||||
| Maxine Gowen | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Maxine Gowen | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Maxine Gowen | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Maxine Gowen | Option exercise | Common Stock | 11,580 | - footnote F1 | - | |
| ||||||
 Jesse Wayne Hall - Officer | Option exercise | Common Stock | 36,375 | - footnote F1 | - | |
| Jesse Wayne Hall - Officer | Tax withholding / forfeiture | Common Stock | 9,330 | $4.41 | $41K | |
| Jesse Wayne Hall - Officer | Option exercise | Restricted Stock Units | 36,375 | $0.00 | - | |
| ||||||
| Braden Michael Leonard | Open-market sale | Common Stock | 300,000 | $4.53 | $1.36M | |
 Kevin Balthaser - Officer | Option exercise | Common Stock | 2,375 | - footnote F1 | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 677 | $2.87 | $2K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 2,375 | $0.00 | - | |
| ||||||
 Neal Walker - Officer | Grant or award | Restricted Stock Units | 274,800 | $0.00 | - | |
| Neal Walker - Officer | Grant or award | Employee Stock Option (Right to Buy) | 961,700 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Restricted Stock Units | 96,100 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Employee Stock Option (Right to Buy) | 336,300 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Restricted Stock Units | 95,700 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Employee Stock Option (Right to Buy) | 334,900 | $0.00 | - | |
| Jesse Wayne Hall - Officer | Grant or award | Restricted Stock Units | 98,100 | $0.00 | - | |
| Jesse Wayne Hall - Officer | Grant or award | Employee Stock Option (Right to Buy) | 343,300 | $0.00 | - | |
 James Loerop - Officer | Grant or award | Restricted Stock Units | 97,700 | $0.00 | - | |
| James Loerop - Officer | Grant or award | Employee Stock Option (Right to Buy) | 341,900 | $0.00 | - | |
| Kevin Balthaser - Officer | Grant or award | Restricted Stock Units | 99,100 | $0.00 | - | |
| Kevin Balthaser - Officer | Grant or award | Employee Stock Option (Right to Buy) | 346,800 | $0.00 | - | |
| James Loerop - Officer | Option exercise | Common Stock | 20,875 | - footnote F1 | - | |
| James Loerop - Officer | Tax withholding / forfeiture | Common Stock | 5,937 | $3.47 | $21K | |
| James Loerop - Officer | Option exercise | Restricted Stock Units | 20,875 | $0.00 | - | |
| ||||||
| Neal Walker - Officer | Option exercise | Common Stock | 63,475 | - footnote F1 | - | |
| Neal Walker - Officer | Tax withholding / forfeiture | Common Stock | 18,611 | $3.47 | $65K | |
| Neal Walker - Officer | Option exercise | Restricted Stock Units | 63,475 | $0.00 | - | |
| ||||||
| Hugh M. Davis - Officer | Option exercise | Common Stock | 18,675 | - footnote F1 | - | |
| Hugh M. Davis - Officer | Option exercise | Restricted Stock Units | 18,675 | $0.00 | - | |
| ||||||
| Kevin Balthaser - Officer | Option exercise | Common Stock | 22,025 | - footnote F1 | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 6,449 | $3.47 | $22K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 22,025 | $0.00 | - | |
| ||||||
| Kevin Balthaser - Officer | Option exercise | Common Stock | 14,750 | - footnote F1 | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 4,984 | $3.51 | $17K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 14,750 | $0.00 | - | |
| ||||||
| James Loerop - Officer | Tax withholding / forfeiture | Common Stock | 15,980 | $2.48 | $40K | |
| Hugh M. Davis - Officer | Option exercise | Common Stock | 26,750 | - footnote F1 | - | |
| Hugh M. Davis - Officer | Option exercise | Restricted Stock Units | 26,750 | $0.00 | - | |
| ||||||
| Roland Wilhelm Kolbeck - Officer | Grant or award | Restricted Stock Units | 145,500 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Employee Stock Option (right to buy) | 510,000 | $0.00 | - | |
| Maxine Gowen | Option exercise | Common Stock | 4,793 | - | - | |
| Maxine Gowen | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Maxine Gowen | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Maxine Gowen | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Vincent Milano | Option exercise | Common Stock | 4,793 | - | - | |
| Vincent Milano | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Vincent Milano | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Vincent Milano | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Common Stock | 4,793 | - | - | |
| Andrew N. Schiff | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Andrew N. Schiff | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Joseph Monahan - Officer | Gift | Common Stock | 15,000 | $0.00 | - | |
| Neal Walker - Officer | Option exercise | Common Stock | 118,840 | $1.52 | $181K | |
| Neal Walker - Officer | Tax withholding / forfeiture | Common Stock | 68,343 | $3.76 | $257K | |
| Neal Walker - Officer | Option exercise | Employee Stock Option (right to buy) | 118,840 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Employee Stock Option (Right to Buy) | 375,000 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Restricted Stock Units | 107,000 | $0.00 | - | |
Item 1.01, 9.01
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
ACRS insider trading FAQ
What is the latest insider trade for ACRS?
Aclaris Therapeutics, Inc. (ACRS) had 1 insider filing in the last 90 days, with the most recent on 2026-08-04. The full record for ACRS runs to 34 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACRS stock?
No insider purchases of ACRS were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ACRS stock?
No insider sales of ACRS were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ACRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACRS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Roland Wilhelm Kolbeck view on EDGAR
- - Andrew N. Schiff view on EDGAR
- - Anand Mehra view on EDGAR
- - Christopher P. Molineaux view on EDGAR
- - William D. Humphries view on EDGAR
- - Vincent Milano view on EDGAR
- - Maxine Gowen view on EDGAR
- - Jesse Wayne Hall view on EDGAR
- - Braden Michael Leonard view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ACRS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACRS with a 7-day demo
- ACRS on your watchlist
- Every ACRS Form 4 filing on record
- Up to 3 months of ACRS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
